Science and Medicine Group

Instrument Business Outlook Volume 29 - Issue 17 15 Dec 2020

Show:


Report details 7 Figures 20 Tables Lab Tool M&A 2020: Activity Picks Up M&A in General Target Markets Building Businesses Diving into New Markets Divestments 2021 Agilent, PerkinElmer and QIAGEN Provide a New Look at Their Scientific Tool Busi… Agilent Technologies: A Path to Further Growth PerkinElmer: The Life Science Story QIAGEN: Focusing on Strengths Executive Briefing QIAGEN, Tecan and Thermo Fisher Raise Sales Forecasts MTS Systems Set to Be Acquired ZEISS Invests in Imaging Software Sartorius Adds to Filtration Business Certara Completes IPO Seer Share Price Skyrockets 908 Devices Sets IPO Terms Calibre Scientific Expands in North America Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu Biotage Reports Strong Sales in China and the Europe & EMEA Region Bio-Techne Starts Fiscal 2021 with Strong Sales Growth HORIBA Posts Sequential Sales Growth Shimadzu Sees Slow Recovery in Academic and Government Markets Market Profile: Mixed-mode Chromatography Leading Vendors Largest Markets Column Cost Resin Cost Industry Watch Biopharmaceutical Chemicals Food Region Watch UK Spain South Korea News Sequencing Company Announcements Product Introductions Sales and Orders of Note MS & LC/MS Company Announcements Product Introductions Chromatography Company Announcements Product Introductions Sales and Orders of Note Bioprocess Company Announcements Sales and Orders of Note Process Analysis Product Introductions Materials Characterization Company Announcements Product Introductions Bottom Line Attachments IBO 121520 Issue.pdf	Third Quarter Results: Biotage, Bio-Techne, HORIBA and Shimadzu Showing 5 figures from this chapter. See all 7 figures in this report. Biotage Q3 FY20 Sales Change. Comparison Source: Science and Medicine Group Bio-Techne Q1 FY21 Sales Comparison by Divisions Source: Science and Medicine Group HORIBA Q3 FY20 Operating Profit Comparison of Process & Environmental and Scientific Instruments (SI) Source: Science and Medicine Group Shimadzu AMI H1 FY21 End-Market Sales Breakdown Notes: The graph reflects Shimadzu AMI's H1 FY21 end-market sales. Source: Science and Medicine Group Shimadzu AMI Q2 FY21 Sales Comparison of Key Models and Other Models Source: Science and Medicine Group Previous Chapter \| Next Chapter To the Top	Actions Copy to clippings Translate Download chapter figures Compare Report Downloads Download the whole report to Word Download the whole report to PDF Download all tables to Excel Download all figures to PowerPoint Attachments IBO 121520 Issue.pdf